Lynette A. Denny, MD, PhD | Authors

Questions We Should Be Asking About Bevacizumab for Cervical Cancer

May 15, 2015

There is good evidence that angiogenesis plays a central role in cervical cancer pathogenesis, suggesting a strong rationale for adding anti-angiogenesis agents to chemotherapeutic agents for the treatment of this disease.